Health and Life Sciences at the Edge: Improving the Accuracy of Medical Imaging Analysis with Artificial Intelligence

 

 

Medical imaging is pioneering the use of AI and analytics to improve the way healthcare is delivered. As the Head of Health Solutions for Intel’s Internet of Things Group, in the Health and Life Sciences and Emerging Technology organization, Alex Flores is uniquely qualified to talk about how AI and Edge technologies are improving the accuracy of medical imaging analysis. This trend began about ten years ago and has accelerated rapidly over the past three years.

“In July of 2020, Intel conducted a survey of over 200 US healthcare leaders. We were looking at key technology trends and the way technology needs have changed post-COVID-19,” Flores said. “We learned that about 45% of the respondents were using, or planning to use, AI in 2020 before COVID-19. That percentage jumped to about 84% since the onset of COVID-19.”

Flores discussed the benefits and problems associated with integrating Edge technology and AI into medical imaging. While adding more compute to or next to devices can shorten the time needed for clinicians to do their jobs, it can also create challenges for manufacturers of Edge devices.

“Edge computing is about doing more processing on or next to a device,” said Flores. “But when you add an external device, power consumption and acoustics become an issue. You can’t just stuff more power-hungry GPUs into an Edge device because they will increase fan size and noise. Imagine sitting in a clinician’s office reviewing your results but not being able to hear because the Edge server under their desk is too loud.”

It’s estimated that the health and life sciences industry produces about a third of the world’s data. But less than three percent of that data has been analyzed. Flores believes that by partnering with health and life sciences industry leaders to address the challenges of harnessing these vast amounts of data Intel can help them come up with actionable insights.

“In my opinion, we haven’t even scratched the surface of what is possible,” Flores said. “We work with our partners to architect optimum hardware platforms, then layer the right software tools to ensure that the solution is optimized to meet their needs. The exciting promise of AI in medical imaging is that it has progressed significantly and in my opinion is continuing to accelerate.”

Learn more about improving the accuracy of medical imaging analysis with AI by connecting with Alex Flores on LinkedIn or visit http://www.intel.com/healthcare

Subscribe to this channel on Apple Podcasts, Spotify, or Google Podcasts to hear more from the Intel Internet of Things Group.

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More